BRIEF-Anika Therapeutics announces Canadian launch of cingal

Thu May 19, 2016 9:44am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 19 (Reuters) - Anika Therapeutics Inc

* Announces Canadian launch of cingal for the treatment of pain associated with osteoarthritis of the knee

* Cingal will be marketed and sold in Canada by Pendopharm, a division of Pharmascience Inc, a Quebec-based pharmaceutical company Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)